United States Type 2 Diabetes Therapeutics Market Report 2017

United States Type 2 Diabetes Therapeutics Market Report 2017

1 Type 2 Diabetes Therapeutics Overview

1.1 Product Overview and Scope of Type 2 Diabetes Therapeutics

1.2 Classification of Type 2 Diabetes Therapeutics

1.2.1 DPP-4 Inhibitors

1.2.2 Biguanides

1.2.3 Insulins

1.2.4 SGLT-2 Inhibitors

1.2.5 ?-Glucosidase Inhibitors

1.2.6 Other

1.3 Application of Type 2 Diabetes Therapeutics

1.3.1 Children

1.3.2 Middle-Aged Person

1.3.3 Aged

1.4 United States Market Size Sales (Volume) and Revenue (Value) of Type 2 Diabetes Therapeutics (2012-2022)

1.4.1 United States Type 2 Diabetes Therapeutics Sales and Growth Rate (2012-2022)

1.4.2 United States Type 2 Diabetes Therapeutics Revenue and Growth Rate (2012-2022)

2 United States Type 2 Diabetes Therapeutics Competition by Manufacturers

2.1 United States Type 2 Diabetes Therapeutics Sales and Market Share of Key Manufacturers (2015 and 2016)

2.2 United States Type 2 Diabetes Therapeutics Revenue and Share by Manufactures (2015 and 2016)

2.3 United States Type 2 Diabetes Therapeutics Average Price by Manufactures (2015 and 2016)

2.4 Type 2 Diabetes Therapeutics Market Competitive Situation and Trends

2.4.1 Type 2 Diabetes Therapeutics Market Concentration Rate

2.4.2 Type 2 Diabetes Therapeutics Market Share of Top 3 and Top 5 Manufacturers

2.4.3 Mergers & Acquisitions, Expansion

3 United States Type 2 Diabetes Therapeutics Sales (Volume) and Revenue (Value) by States (2012-2017)

3.1 United States Type 2 Diabetes Therapeutics Sales and Market Share by States (2012-2017)

3.2 United States Type 2 Diabetes Therapeutics Revenue and Market Share by States (2012-2017)

3.3 United States Type 2 Diabetes Therapeutics Price by States (2012-2017)

4 United States Type 2 Diabetes Therapeutics Sales (Volume) and Revenue (Value) by Type (2012-2017)

4.1 United States Type 2 Diabetes Therapeutics Sales and Market Share by Type (2012-2017)

4.2 United States Type 2 Diabetes Therapeutics Revenue and Market Share by Type (2012-2017)

4.3 United States Type 2 Diabetes Therapeutics Price by Type (2012-2017)

4.4 United States Type 2 Diabetes Therapeutics Sales Growth Rate by Type (2012-2017)

5 United States Type 2 Diabetes Therapeutics Sales (Volume) by Application (2012-2017)

5.1 United States Type 2 Diabetes Therapeutics Sales and Market Share by Application (2012-2017)

5.2 United States Type 2 Diabetes Therapeutics Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Type 2 Diabetes Therapeutics Manufacturers Profiles/Analysis

6.1 AstraZeneca

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Type 2 Diabetes Therapeutics Product Type, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 AstraZeneca Type 2 Diabetes Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Novartis

6.2.2 Type 2 Diabetes Therapeutics Product Type, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Novartis Type 2 Diabetes Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Novo Nordisk

6.3.2 Type 2 Diabetes Therapeutics Product Type, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Novo Nordisk Type 2 Diabetes Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Boehringer Ingelheim

6.4.2 Type 2 Diabetes Therapeutics Product Type, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Boehringer Ingelheim Type 2 Diabetes Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Bristol-Myers Squibb

6.5.2 Type 2 Diabetes Therapeutics Product Type, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Bristol-Myers Squibb Type 2 Diabetes Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Eli Lilly

6.6.2 Type 2 Diabetes Therapeutics Product Type, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Eli Lilly Type 2 Diabetes Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Merck

6.7.2 Type 2 Diabetes Therapeutics Product Type, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Merck Type 2 Diabetes Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Sanofi

6.8.2 Type 2 Diabetes Therapeutics Product Type, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Sanofi Type 2 Diabetes Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

7 Type 2 Diabetes Therapeutics Manufacturing Cost Analysis

7.1 Type 2 Diabetes Therapeutics Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Type 2 Diabetes Therapeutics

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Type 2 Diabetes Therapeutics Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Type 2 Diabetes Therapeutics Major Manufacturers in 2015

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Type 2 Diabetes Therapeutics Market Forecast (2017-2022)

11.1 United States Type 2 Diabetes Therapeutics Sales, Revenue Forecast (2017-2022)

11.2 United States Type 2 Diabetes Therapeutics Sales Forecast by Type (2017-2022)

11.3 United States Type 2 Diabetes Therapeutics Sales Forecast by Application (2017-2022)

11.4 Type 2 Diabetes Therapeutics Price Forecast (2017-2022)

12 Research Findings and Conclusion

13 Appendix

Methodology

Analyst Introduction

Data Source

Figure Picture of Type 2 Diabetes Therapeutics

Table Classification of Type 2 Diabetes Therapeutics

Figure United States Sales Market Share of Type 2 Diabetes Therapeutics by Type in 2015

Figure DPP-4 Inhibitors Picture

Figure Biguanides Picture

Figure Insulins Picture

Figure SGLT-2 Inhibitors Picture

Figure ?-Glucosidase Inhibitors Picture

Figure Other Picture

Table Application of Type 2 Diabetes Therapeutics

Figure United States Sales Market Share of Type 2 Diabetes Therapeutics by Application in 2015

Figure Children Examples

Figure Middle-Aged Person Examples

Figure Aged Examples

Figure United States Type 2 Diabetes Therapeutics Sales and Growth Rate (2012-2022)

Figure United States Type 2 Diabetes Therapeutics Revenue and Growth Rate (2012-2022)

Table United States Type 2 Diabetes Therapeutics Sales of Key Manufacturers (2015 and 2016)

Table United States Type 2 Diabetes Therapeutics Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Type 2 Diabetes Therapeutics Sales Share by Manufacturers

Figure 2016 Type 2 Diabetes Therapeutics Sales Share by Manufacturers

Table United States Type 2 Diabetes Therapeutics Revenue by Manufacturers (2015 and 2016)

Table United States Type 2 Diabetes Therapeutics Revenue Share by Manufacturers (2015 and 2016)

Table 2015 United States Type 2 Diabetes Therapeutics Revenue Share by Manufacturers

Table 2016 United States Type 2 Diabetes Therapeutics Revenue Share by Manufacturers

Table United States Market Type 2 Diabetes Therapeutics Average Price of Key Manufacturers (2015 and 2016)

Figure United States Market Type 2 Diabetes Therapeutics Average Price of Key Manufacturers in 2015

Figure Type 2 Diabetes Therapeutics Market Share of Top 3 Manufacturers

Figure Type 2 Diabetes Therapeutics Market Share of Top 5 Manufacturers

Table United States Type 2 Diabetes Therapeutics Sales by States (2012-2017)

Table United States Type 2 Diabetes Therapeutics Sales Share by States (2012-2017)

Figure United States Type 2 Diabetes Therapeutics Sales Market Share by States in 2015

Table United States Type 2 Diabetes Therapeutics Revenue and Market Share by States (2012-2017)

Table United States Type 2 Diabetes Therapeutics Revenue Share by States (2012-2017)

Figure Revenue Market Share of Type 2 Diabetes Therapeutics by States (2012-2017)

Table United States Type 2 Diabetes Therapeutics Price by States (2012-2017)

Table United States Type 2 Diabetes Therapeutics Sales by Type (2012-2017)

Table United States Type 2 Diabetes Therapeutics Sales Share by Type (2012-2017)

Figure United States Type 2 Diabetes Therapeutics Sales Market Share by Type in 2015

Table United States Type 2 Diabetes Therapeutics Revenue and Market Share by Type (2012-2017)

Table United States Type 2 Diabetes Therapeutics Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Type 2 Diabetes Therapeutics by Type (2012-2017)

Table United States Type 2 Diabetes Therapeutics Price by Type (2012-2017)

Figure United States Type 2 Diabetes Therapeutics Sales Growth Rate by Type (2012-2017)

Table United States Type 2 Diabetes Therapeutics Sales by Application (2012-2017)

Table United States Type 2 Diabetes Therapeutics Sales Market Share by Application (2012-2017)

Figure United States Type 2 Diabetes Therapeutics Sales Market Share by Application in 2015

Table United States Type 2 Diabetes Therapeutics Sales Growth Rate by Application (2012-2017)

Figure United States Type 2 Diabetes Therapeutics Sales Growth Rate by Application (2012-2017)

Table AstraZeneca Basic Information List

Table AstraZeneca Type 2 Diabetes Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

Figure AstraZeneca Type 2 Diabetes Therapeutics Sales Market Share (2012-2017)

Table Novartis Basic Information List

Table Novartis Type 2 Diabetes Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

Table Novartis Type 2 Diabetes Therapeutics Sales Market Share (2012-2017)

Table Novo Nordisk Basic Information List

Table Novo Nordisk Type 2 Diabetes Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

Table Novo Nordisk Type 2 Diabetes Therapeutics Sales Market Share (2012-2017)

Table Boehringer Ingelheim Basic Information List

Table Boehringer Ingelheim Type 2 Diabetes Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

Table Boehringer Ingelheim Type 2 Diabetes Therapeutics Sales Market Share (2012-2017)

Table Bristol-Myers Squibb Basic Information List

Table Bristol-Myers Squibb Type 2 Diabetes Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

Table Bristol-Myers Squibb Type 2 Diabetes Therapeutics Sales Market Share (2012-2017)

Table Eli Lilly Basic Information List

Table Eli Lilly Type 2 Diabetes Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

Table Eli Lilly Type 2 Diabetes Therapeutics Sales Market Share (2012-2017)

Table Merck Basic Information List

Table Merck Type 2 Diabetes Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

Table Merck Type 2 Diabetes Therapeutics Sales Market Share (2012-2017)

Table Sanofi Basic Information List

Table Sanofi Type 2 Diabetes Therapeutics Sales, Revenue, Price and Gross Margin (2012-2017)

Table Sanofi Type 2 Diabetes Therapeutics Sales Market Share (2012-2017)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Type 2 Diabetes Therapeutics

Figure Manufacturing Process Analysis of Type 2 Diabetes Therapeutics

Figure Type 2 Diabetes Therapeutics Industrial Chain Analysis

Table Raw Materials Sources of Type 2 Diabetes Therapeutics Major Manufacturers in 2015

Table Major Buyers of Type 2 Diabetes Therapeutics

Table Distributors/Traders List

Figure United States Type 2 Diabetes Therapeutics Production and Growth Rate Forecast (2017-2022)

Figure United States Type 2 Diabetes Therapeutics Revenue and Growth Rate Forecast (2017-2022)

Table United States Type 2 Diabetes Therapeutics Production Forecast by Type (2017-2022)

Table United States Type 2 Diabetes Therapeutics Consumption Forecast by Application (2017-2022)

Table United States Type 2 Diabetes Therapeutics Sales Forecast by States (2017-2022)

Table United States Type 2 Diabetes Therapeutics Sales Share Forecast by States (2017-2022)